Evidence map›Paper›PMID 34863618›Full record

Trial reportVaccine2022

Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington.

Julia H Rogers, Sarah N Cox, James P Hughes, Amy C Link, Eric J Chow, Idabelle Fosse, Margaret Lukoff, M Mia Shim, Timothy M Uyeki, Constance Ogokeh and 6 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04141917 (Stepped-wedge Design Study of Point-of-care Molecular Testing for Influenza and Treatment With Baloxavir for Prevention of Secondary Transmission of Influenza in Homeless Shelters in Seattle, WA), which is not on this map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04141917 phase4terminatednot on this map

Stepped-wedge Design Study of Point-of-care Molecular Testing for Influenza and Treatment With Baloxavir for Prevention of Secondary Transmission of Influenza in Homeless Shelters in Seattle, WA

TypeinterventionalSponsorUniversity of WashingtonRan2019 to 2021Enrolled1,618ConditionsInfluenza, Respiratory Viral InfectionArmsPoint-of-care molecular testing and treatment of influenza
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Implementing a COVID-19 vaccination outreach service for people experiencing homelessness.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. COVID-19 Vaccine Hesitancy among U.S. Veterans Experiencing Homelessness in Transitional Housing.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Julia H RogersDepartment of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA. Electronic address: Jr66@uw.edu.
Sarah N CoxDepartment of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
James P HughesDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Amy C LinkDepartment of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
Eric J ChowDepartment of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
Idabelle FossePublic Health - Seattle & King County, WA, USA.
Margaret LukoffPublic Health - Seattle & King County, WA, USA.
M Mia ShimPublic Health - Seattle & King County, WA, USA; Department of Medicine, Division of General Internal Medicine, University of Washington, Seattle, WA, USA.
Timothy M UyekiCenters for Disease Control and Prevention, Atlanta, GA, USA.
Constance OgokehCenters for Disease Control and Prevention, Atlanta, GA, USA.
Michael L JacksonKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Michael BoeckhFred Hutchinson Cancer Research Center Seattle, WA, USA.
Janet A EnglundSeattle Children's Research Institute, University of Washington, Seattle, WA, USA.
Emily MositesCenters for Disease Control and Prevention, Atlanta, GA, USA.
Melissa A RolfesCenters for Disease Control and Prevention, Atlanta, GA, USA.
Helen Y ChuDepartment of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA.
University of Washington · USCenters for Disease Control and Prevention · USPublic Health – Seattle & King County · USFred Hutch Cancer Center · USKaiser Permanente Washington Health Research Institute · US

Funding

HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

introductionLittle is known about COVID-19 vaccination intent among people experiencing homelessness. This study assesses surveyed COVID-19 vaccination intent among adult homeless shelter residents and staff and identifies factors associated with vaccine deliberation (responded "undecided") and reluctance (responded "no"), including time trends.

methodsFrom 11/1/2020-2/28/21, we conducted repeated cross-sectional surveys at nine shelters in King County, WA as part of ongoing community-based SARS-CoV-2 surveillance. We used a multinomial model to identify characteristics associated with vaccine deliberation and reluctance.

resultsA total of 969 unique staff (n = 297) and residents (n = 672) participated and provided 3966 survey responses. Among residents, 53.7% (n = 361) were vaccine accepting, 28.1% reluctant, 17.6% deliberative, and 0.6% already vaccinated, whereas among staff 56.2% were vaccine accepting, 14.1% were reluctant, 16.5% were deliberative, and 13.1% already vaccinated at their last survey. We observed higher odds of vaccine deliberation or reluctance among Black/African American individuals, those who did not receive a seasonal influenza vaccine, and those with lower educational attainment. There was no significant trend towards vaccine acceptance.

conclusionsStrong disparities in vaccine intent based on race, education, and prior vaccine history were observed. Increased vaccine intent over the study period was not detected. An intersectional, person-centered approach to addressing health inequities by public health authorities planning vaccination campaigns in shelters is recommended. Clinical Trial Registry Number: NCT04141917.

Indexed as

COVID-19Ill-Housed PersonsAdultCOVID-19 VaccinesCross-Sectional StudiesHealth InequitiesHumansSARS-CoV-2VaccinationWashingtonCOVID-19 VaccinesCOVID-19Health inequitiesHomelessSARS-CoV-2ShelterVaccination

Identifiers

PMID34863618
PMCPMC8590934
OpenAlexW3212146832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.